20 Physics "University Medical Centre Utrecht" Fellowship positions at Nature Careers
Sort by
Refine Your Search
-
the Faculty of Engineering and Science . Required qualifications The applicant for the PhD position must hold a master’s degree in physics or nanotechnology or a closely related field. In addition, we require a
-
Introduction of DICP The Dalian Institute of Chemical Physics (DICP) is located in the port city of Dalian, China. In the past half century, research at DICP has closely reflected the economic and
-
for defining novel correlates of protection to various vaccines and infectious diseases. Acquire, process, integrate, and standardize large datasets and build databases. Perform integrative and exploratory
-
be in the process of either completing their PhDs and/or have received their PhD after May 1, 2023. Fellows must have completed their doctoral degree prior to starting their Fellowship term. Edwin Land
-
parts of the hiring process as required under our Access for People with Disabilities policy. Applicants need to make their requirements known in advance. The Lunenfeld-Tanenbaum Research Institute is a
-
commence as soon as possible and will continue until the positions are filled. The personal data provided during the application process will be used for recruitment and other employment-related purposed
-
infrastructure, has woven an extensive academic and research network, and its recruitment process is seeking outstanding academics and professionals to promote Morocco and Africa’s innovation ecosystem. About the
-
their applications Applicants cannot hold a faculty position at the time they expect to commence their fellowship Application Process Candidates must submit a written application by June 26, 2024 via WRF’s website
-
academic and research network, and its recruitment process is seeking outstanding academics and professionals to promote Morocco and Africa’s innovation ecosystem. About the ABS: The Africa Business School
-
that are physiologically important for a healthy immune system. We are interested in the next generation of therapeutics that will be personalized and only target the original disease process. Such treatments can only be